DOI=10.1007/BF01753729
R. Jacubovich, Jean-Francois Dore;
Tumour-associated antigens in culture medium of malignant melanoma cell strains.
Cancer Immunol. Immunother. 7:59-64(1979)

PubMed=3882112; DOI=10.1038/bjc.1985.45; PMCID=PMC1976943
R. Jacubovich, Helene Cabrillat, Denis Gerlier, Maryse Bailly, Jean-Francois Dore;
Tumourigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumour mechanism.
Br. J. Cancer 51:335-345(1985)

DOI=10.1159/000417158
Suzanne Bertrand, Maryse Bailly, Marie-Jeanine Nguyen, Jean-Francois Dore;
Cytogenetic characterization of human melanoma metastatic variants: role of chromosome 7?
(In book chapter) Immune-deficient animals in experimental medicine; Wu, Bing-Quan & Zheng, Jie (eds.); pp.135-139; Karger; Basel; Switzerland (1989)

DOI=10.1159/000417159
Maryse Bailly, Suzanne Bertrand, Jean-Francois Dore;
Experimental model of human tumor spontaneous metastasis in immunosupressed newborn rat.
(In book chapter) Immune-deficient animals in experimental medicine; Wu, Bing-Quan & Zheng, Jie (eds.); pp.140-146; Karger; Basel; Switzerland (1989)

PubMed=1937961; DOI=10.1002/ijc.2910490520
Maryse Bailly, Jean-Francois Dore;
Human tumor spontaneous metastasis in immunosuppressed newborn rats II. Multiple selections of human melanoma metastatic clones and variants.
Int. J. Cancer 49:750-757(1991)

PubMed=1503405
Maryse Bailly, Jean-Francois Dore;
Clonal drift and role of chromosome dosage in human melanoma metastatic cell lines: a statistical analysis.
Anticancer Res. 12:1163-1172(1992)

PubMed=8471837; DOI=10.1097/00008390-199304000-00008
Maryse Bailly, Suzanne Bertrand, Jean-Francois Dore;
Increased spontaneous mutation rates and prevalence of karyotype abnormalities in highly metastatic human melanoma cell lines.
Melanoma Res. 3:51-61(1993)

PubMed=8012932; DOI=10.1016/0304-3835(94)90197-x
Anne Mey, Odile Berthier-Vergnes, Pol Andre Apoil, Jean-Francois Dore, Jean-Pierre Revillard;
Expression of the galactose binding protein Mac-2 by human melanoma cell-lines.
Cancer Lett. 81:155-163(1994)

PubMed=8125107; DOI=10.1111/j.1432-1033.1994.tb18647.x
Habib Boukerche, Miloud Benchaibi, Odile Berthier-Vergnes, Gerard Lizard, Maryse Bailly, Mireille Bailly, John L. McGregor;
Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit.
Eur. J. Biochem. 220:485-491(1994)

PubMed=8175891; DOI=10.1002/jcb.240540205
Noureddine Zebda, Maryse Bailly, Spencer Craig Brown, Jean-Francois Dore, Odile Berthier-Vergnes;
Expression of PNA-binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential.
J. Cell. Biochem. 54:161-173(1994)

PubMed=7874696; DOI=10.1016/0304-3835(94)03624-r
Charles P. Thomas, Anna Buronfosse, Jacques Portoukalian, Bernard Fertil;
Correlation between the radiosensitivity in vitro of clones and variants derived from a human melanoma cell line and their spontaneous metastatic potential in vivo.
Cancer Lett. 88:221-225(1995)

PubMed=9043018; DOI=10.1038/bjc.1997.115; PMCID=PMC2063334
Charles P. Thomas, Anna Buronfosse, Jacques Portoukalian, Bernard Fertil;
The gangliosides as a possible molecular coupling factor between the proportion of radiosensitive cells in vitro and the metastatic potential in vivo within a human melanoma cell line.
Br. J. Cancer 75:639-649(1997)

PubMed=17970093
Francois Bertucci, Cecile Pages, Pascal Finetti, Philippe Rochaix, Laurence Lamant, Elizabeth Devilard, Cathy Nguyen, Remi Houlgatte, Daniel Birnbaum, Luc Xerri, Pierre Brousset;
Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.
Anticancer Res. 27:3441-3449(2007)